Axsome Therapeutics
AXSM
AXSM
11 hedge funds and large institutions have $47.7M invested in Axsome Therapeutics in 2015 Q4 according to their latest regulatory filings, with 11 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
11
Holders Change
+11
Holders Change %
–
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Fidelity Investments
Boston,
Massachusetts
| $26.2M | 2,870,570 | +2,870,570 | New |
|
2
JPMorgan Chase & Co
New York
| $14.2M | 1,555,409 | +1,555,409 | New |
|
|
LOAMU
3
Lombard Odier Asset Management (USA)
New York
| $3.11M | 341,092 | +341,092 | New |
|
|
SFM
4
Sphera Funds Management
Tel Aviv,
Israel
| $2.01M | 220,000 | +220,000 | New |
|
5
Allianz Asset Management
Munich,
Germany
| $1.08M | 117,165 | +117,165 | New |
|
6
Millennium Management
New York
| $517K | 55,809 | +55,809 | New |
|
7
Goldman Sachs
New York
| $226K | 24,426 | +24,426 | New |
|
|
BFA
8
BlackRock Fund Advisors
San Francisco,
California
| $127K | 13,729 | +13,729 | New |
|
9
Bank of New York Mellon
New York
| $107K | 11,512 | +11,512 | New |
|
10
Morgan Stanley
New York
| $64K | 6,870 | +6,870 | New |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| $3K | 324 | +324 | New |
|